Cyclosporin in the Therapy of Idiopathic Nephrotic Syndrome in Children

  • P. Niaudet
  • M. Broyer
Part of the International Yearbooks of Nephrology book series (IYNE, volume 1)

Abstract

Idiopathic nephrotic syndrome, which is the most frequent glomerular disease in children, is defined by the combination of nephrotic syndrome and minimal change glomerular disease, with foot process fusion on electron microscopy. No immunoglobulin or complement fraction deposits are seen on immunofluorescent examination. However, in some cases, diffuse mesangial proliferation or focal and segmental glomerulosclerosis may be seen on light microscopy. In addition, immunofluorescent examination sometimes reveals mesangial immunoglobulin deposits found either in isolation or in association with C1q and/or C3 deposits. The most frequently found immunoglobulin is IgM, leading some authors to consider IgM nephropathy as a disease entity (1). IgA deposits have also been found in some patients (2, 3) as well as granular C3 deposits.

Keywords

Leukemia Interferon Nylon Cyclosporin Cyclophosphamide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cohen, A.H., Border, W.A. and Glassock, R.J. Nephrotic syndrome with glomerular mesangial IgM deposits. Lab. Invest. 38: 610–619, 1978.PubMedGoogle Scholar
  2. 2.
    Katz, A., Walker, J.F. and Landy, P.J. IgA nephritis with nephrotic range proteinuria. Clin. Nephrol. 20: 67–71, 1983.PubMedGoogle Scholar
  3. 3.
    Mustonen, J., Pasternack, A. and Rantala, I. The nephrotic syndrome in IgA glomerulonephritis: response to corticosteroid therapy. Clin. Nephrol. 20: 172–176, 1983.PubMedGoogle Scholar
  4. 4.
    Habib, R. and Churg, J. Minimal change disease, mesangial proliferation glomerulonephritis and focal sclerosis: individual entities or a spectrum. IN: Nephrology (Ed. R.R. Robinson) Springer Verlag, New York, 1554, pp. 634–644.Google Scholar
  5. 5.
    Borel, J.F., Gubler, H.U. and Stahelin, H. The biological effects of Cyclosporine A: A new antilymphocyte agent. Agents Actions. 6: 468–475, 1976.PubMedCrossRefGoogle Scholar
  6. 6.
    Cohen, D.J., Loertscher, R., Rubin, M.F., Tilney, N.L., Carpenter, C.B. and Strom, T.B. Cyclosporine: A new immunosuppressive agent for organ transplantation. Ann. Intern. Med. 101: 667–682, 1984.PubMedGoogle Scholar
  7. 7.
    Nelson, P.W. Cyclosporine. Surg. Gynecol. Obstet. 159: 297–308, 1984.Google Scholar
  8. 8.
    Bunjes, D., Hardt, C., Rollinghoff, M. and Wagner, H. Cyclosporine A mediates immunosuppression of primary cytotoxic T-cell responses by impairing the release of interleukine 1 and interleukine 2. Eur. J. Immunol. 11: 657–661, 1981.PubMedCrossRefGoogle Scholar
  9. 9.
    Hess, A.D., Tutschka, P.J. and Santos, G.W. Effect of Cyclosporine A on human lymphocyte responses in vitro: II induction of specific alloantigen unresponsiveness mediated by nylon wool adherent suppressor cell. J. Immunol 126: 961–968, 1981.PubMedGoogle Scholar
  10. 10.
    Brouhard, B.H., Goldblum, R.M., Bunce, H. and Cunningham, R.J. Immunoglobulin synthesis and urinary IgG excretion in the idiopathic nephrotic syndrome of children. Int. J. Pediatr. Nephrol. 2: 163–169, 1981.Google Scholar
  11. 11.
    Giangiacomo, J., Cleary, T.G., Cole, B.R., Hoffsten, P., Robson, A.M. Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal change nephrotic syndrome. N. Engl. J. Med. 293: 8–12, 1975.PubMedCrossRefGoogle Scholar
  12. 12.
    Heslan, J.M., Lautie, J.P., Intrator, L., Blanc, C., Lagrue, G. and Sobel, A.T. Impaired IgG synthesis in patients with the nephrotic syndrome. Clin. Nephrol. 18: 144–147, 1982.PubMedGoogle Scholar
  13. 13.
    Dall’Aglio, P. Minimal change glomerulonephritis and focal glomerulosclerosis: markers and in vitro activity of peripheral blood mononuclear cells. Proc. Eur. Dial. Transplant. Assoc. 19: 673–678, 1982.Google Scholar
  14. 14.
    Fodor, P., Saitua, M.T., Rodriguez, E., Gonzales, B. and Schlesinger, L. T-cell dysfunction in minimal-change nephrotic syndrome of childhood. Am. J. Dis. Child. 136: 713–717, 1982.PubMedGoogle Scholar
  15. 15.
    Matsumoto, K., Osakabe, K., Harada, M. and Matano, M. Impaired cell-mediated immunity in lipoid nephrosis. Nephron 29: 190–194, 1981.PubMedCrossRefGoogle Scholar
  16. 16.
    Eyres, K., Mallick, N.P. and Taylor, G. Evidence for cell-mediated immunity to renal antigens in minimal-change nephrotic syndrome. Lancet 1: 1158–1159, 1976.PubMedCrossRefGoogle Scholar
  17. 17.
    Minchin, M.A., Turner, K.J. and Bower, G.D. Lymphocyte histogenesis in nephrotic syndrome. Clin. Exp. Immunol. 42: 241–246, 1980.PubMedGoogle Scholar
  18. 18.
    Mallick, N.P., Williams, R.J., McFarlane, H., Orr, W.M., Taylor, G. and Williams, G. Cell-mediated immunity in nephrotic syndrome. Lancet 1: 507–509, 1972.PubMedCrossRefGoogle Scholar
  19. 19.
    Schnaper, H.W. and Aune, T.M. Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children. J. Clin. Invest. 76: 341–349, 1985.PubMedCrossRefGoogle Scholar
  20. 20.
    Lagrue, G., Branellec, A. and Blanc, C. A vascular permeability factor in lymphocyte culture supernatants from patients with nephrotic syndrome. II Pharmalogical and physicochemical properties. Biomedecine 23: 73–75, 1975.PubMedGoogle Scholar
  21. 21.
    Shalhoub, R.J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2: 556–559, 1974.PubMedCrossRefGoogle Scholar
  22. 22.
    Hoyer, P.F., Krull, F. and Brodehl, J. Cyclosporin in frequently relapsing minimal change nephrotic syndrome. Lancet 2: 335, 1986.PubMedCrossRefGoogle Scholar
  23. 23.
    Capodicasa, G., De Santo, N.G., Nuzzi, F. and Giordano, C. Cyclosporin A in nephrotic syndrome of childhood: a 14 month experience. Int. J. Pediatr. Nephrol. 7: 69–72, 1986.PubMedGoogle Scholar
  24. 24.
    Niaudet, P., Habib, R., Tete, M.J., Hinglais, N. and Broyer, M. Cyclosporin in the treatment of idiopathic nephrotic syndrome in children. Pediatr. Nephrol. 1: 566–573, 1987.PubMedCrossRefGoogle Scholar
  25. 25.
    Tejani, A., Butt, K., Trachtman, H., Suthanthiran, M., Rosenthal, C.J. and Khawar, M.R. Cyclosporine-induced remission of relapsing nephrotic syndrome in children. J. Pediatr. 111 (6, part 2): 1056–1062, 1987.PubMedCrossRefGoogle Scholar
  26. 26.
    Tejani, A., Butt, K., Trachtman, H., Suthanthiran, M., Rosenthal, C.J. and Khawar, M.R., Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int. 33: 729–734, 1988.PubMedCrossRefGoogle Scholar
  27. 27.
    Brandis, M., Burghard, R., Leititis, J., Zimmerhackl, B., Hildebrandt, F. and Helmcher, U. Cyclosporin A for treatment in nephrotic syndrome. Pediatr. Nephrol. 1: C42, 1987.CrossRefGoogle Scholar
  28. 28.
    Waldo, F.B. and Kohaut, E.C. Therapy of focal segmental glomerulosclerosis with Cyclosporine A. Pediatr. Nephrol. 1: 180–182, 1987.PubMedCrossRefGoogle Scholar
  29. 29.
    Brodehl, J., Ehrich, J.J.H., Hoyer, P.F., Lee, I.J., Oemar, B.S. and Wonigeit, K. Cyclosporin A treatment of minimal change nephrotic syndrome and focal segmental glomerulosclerosis in children. Korean J. Nephrol. 6: 26–33, 1987.Google Scholar
  30. 30.
    Myers, B.D. Cyclosporine nephrotoxicity. Kidney In 30: 964–974, 1986.CrossRefGoogle Scholar
  31. 31.
    Meyrier, A., Simon, P., Perret, G. and Condamin-Meyrier, M.C. Remission of idiopathic nephrotic syndrome after treatment with Cyclosporine A. Br. Med. J. 292: 789–792, 1986.CrossRefGoogle Scholar
  32. 32.
    Lagrue, G., Laurent, J., Belghiti, D. and Robeva, R. Cyclosporin and idiopathic nephrotic syndrome. Lancet 2: 692–693, 1986.PubMedCrossRefGoogle Scholar
  33. 33.
    Chan, M.K. and Cheng, I.K.P. Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses. Postgrad. Med. J. 63: 757–759, 1987.PubMedCrossRefGoogle Scholar
  34. 34.
    Meyrier, A. and Simon P. Treatment of cortical resistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis, In: Advances in Nephrology (Eds. Grunfeld, Maxwell, Bach, Crosnier, Funk Bruntano) Year Book Medical Publishers, Inc. 1988, pp. 127–150.Google Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • P. Niaudet
    • 1
  • M. Broyer
    • 1
  1. 1.Service de Nephrologie Pédiatrique and INSERM U 192Hôpital Necker-Enfants MaladesParisFrance

Personalised recommendations